XWPharma Alternatives & Competitors
12 companies similar to XWPharma — Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and ot...
Companies similar to XWPharma
Proniras Corporation
Clinical-stage biotechnology developing therapeutics for the treatment of substance use &...
Seattle, United States
Psy Therapeutics
Creating new futures in central nervous system (CNS) treatment and care.
Boston, United States
Hypnion
Advancing neuroscience to enhance sleep and wake-alertness with innovative treatments for...
Libra Therapeutics
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
San Diego, United States
Track all XWPharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
BlackThorn Therapeutics
Pioneering precision medicine for CNS disorders through advanced computational and clinica...
Myrobalan Therapeutics
Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...
Medford, United States
Allyx Therapeutics
Protecting Synapses and Reversing Neurodegeneration
New Haven, United States
Azevan Pharmaceuticals
Innovative therapies for stress, mood, and behavior disorders
Neumora
Pioneering a new era of medicines for brain diseases
Watertown, United States
Seaport Therapeutics
We are a clinical-stage therapeutics company advancing the development of novel neuropsych...
Boston, United States
Umecrine Cognition AB
A novel and safe approach for treating cognitive disorders
Solna, Sweden
Hinge Therapeutics
Hinge Therapeutics is an early-stage biopharmaceutical company which focuses on developing...
Torrance, United States
About XWPharma
XWPharma is a biotech company with a vision to develop groundbreaking therapeutics for a range of underserved CNS disorders. Established in 2014, the company focuses on the development of novel small molecule drug candidates that target neurological and neuropsychiatric disorders and has a global presence. With a commi...
Neuroscience, Biotech, CNS Disorders, Sleep, Neuropsychiatric Disorders, Narcolepsy, Parkinson's Disease, Depression, Neurological Disorders, Neurodegeneration, Small Molecule Drugs, Novel Therapeutics, Drug Development, Bay Area, Global Biotech
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches XWPharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at XWPharma on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
